Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
N/A
-726,002 Closed
0 $0
Q3 2024

Nov 13, 2025

BUY
$67.3 - $69.67 $48.9 Million - $50.6 Million
726,002 New
726,002 $50.6 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Kite Lake Capital Management (Uk) LLP Portfolio

Follow Kite Lake Capital Management (Uk) LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kite Lake Capital Management (Uk) LLP, based on Form 13F filings with the SEC.

News

Stay updated on Kite Lake Capital Management (Uk) LLP with notifications on news.